Cargando…

Plasma levels of matrix metalloproteinase‐9 (MMP‐9) are associated with cognitive performance in patients with schizophrenia

AIM: Matrix metalloproteinase‐9 (MMP‐9) has been shown to modulate synaptic plasticity and may contribute to the pathophysiology of schizophrenia. This study investigated the peripheral levels of MMP‐9 and its association with cognitive functions in patients with schizophrenia to see the possible in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Noriko, Yamamori, Hidenaga, Ishima, Tamaki, Nemoto, Kiyotaka, Yasuda, Yuka, Fujimoto, Michiko, Azechi, Hirotsugu, Niitsu, Tomihisa, Numata, Shusuke, Ikeda, Manabu, Iyo, Masaomi, Ohmori, Tetsuro, Fukunaga, Masaki, Watanabe, Yoshiyuki, Hashimoto, Kenji, Hashimoto, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722656/ https://www.ncbi.nlm.nih.gov/pubmed/32022478 http://dx.doi.org/10.1002/npr2.12098

Ejemplares similares

Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia
por: Kudo, Noriko, et al.
Publicado: (2018)

S239. PREDICTIVE ACCURACY FOR WORK OUTCOME IN PATIENTS WITH SCHIZOPHRENIA
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Brain morphological and functional features in cognitive subgroups of schizophrenia
por: Yasuda, Yuka, et al.
Publicado: (2019)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Psychological Distress Symptoms Associated With Life Events in Patients With Bipolar Disorder: A Cross-Sectional Study
por: Sato, Aiko, et al.
Publicado: (2018)

Methylation Analysis in Monozygotic Twins With Treatment-Resistant Schizophrenia and Discordant Responses to Clozapine
por: Kikuchi, Masataka, et al.
Publicado: (2021)

Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP(3) Receptors and Cellular Signaling Pathways
por: Nishimura, Tomoko, et al.
Publicado: (2008)

Need for self-medication using over-the-counter psychoactive agents: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2021)

Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan
por: Shiina, Akihiro, et al.
Publicado: (2020)

Perception of and anxiety about COVID-19 infection and risk behaviors for spreading infection: an international comparison
por: Shiina, Akihiro, et al.
Publicado: (2021)

Sex differences of leukocytes DNA methylation adjusted for estimated cellular proportions
por: Inoshita, Masatoshi, et al.
Publicado: (2015)

Differentiation of schizophrenia using structural MRI with consideration of scanner differences: A real‐world multisite study
por: Nemoto, Kiyotaka, et al.
Publicado: (2019)

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia
por: Kinoshita, Makoto, et al.
Publicado: (2017)

Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood
por: Shirai, Yumi, et al.
Publicado: (2015)

Changes in Self-Regulation-Related Prefrontal Activities in Eating Disorders: A Near Infrared Spectroscopy Study
por: Sutoh, Chihiro, et al.
Publicado: (2013)

Increased Serum Levels of Oxytocin in ‘Treatment Resistant Depression in Adolescents (TRDIA)’ Group
por: Sasaki, Tsuyoshi, et al.
Publicado: (2016)

Comparison of eye movements in schizophrenia and autism spectrum disorder
por: Shiino, Tomoko, et al.
Publicado: (2019)

Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial
por: Hashimoto, Tasuku, et al.
Publicado: (2016)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Semantic Memory Organization in Japanese Patients With Schizophrenia Examined With Category Fluency
por: Sumiyoshi, Chika, et al.
Publicado: (2018)

Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole
por: Ishima, T, et al.
Publicado: (2012)

How to diagnose the 22q11.2 deletion syndrome in patients with schizophrenia: a case report
por: Ohi, Kazutaka, et al.
Publicado: (2013)

A Brief Assessment of Intelligence Decline in Schizophrenia As Represented by the Difference between Current and Premorbid Intellectual Quotient
por: Ohi, Kazutaka, et al.
Publicado: (2017)

A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2019)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment
por: Yoshinaga, Naoki, et al.
Publicado: (2013)

Impact of the Genome Wide Supported NRGN Gene on Anterior Cingulate Morphology in Schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2012)

The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia
por: Ohi, Kazutaka, et al.
Publicado: (2013)

Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
por: Huang, Hao
Publicado: (2018)

Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Role of subcortical structures on cognitive and social function in schizophrenia
por: Koshiyama, Daisuke, et al.
Publicado: (2018)

Sensory cognitive abnormalities of pain in autism spectrum disorder: a case–control study
por: Yasuda, Yuka, et al.
Publicado: (2016)

Genome-wide Association Analysis of Eye Movement Dysfunction in Schizophrenia
por: Kikuchi, Masataka, et al.
Publicado: (2018)

Genetic Overlap between General Cognitive Function and Schizophrenia: A Review of Cognitive GWASs
por: Ohi, Kazutaka, et al.
Publicado: (2018)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Suppression of MMP-9 by doxycycline in brain arteriovenous malformations
por: Hashimoto, Tomoki, et al.
Publicado: (2005)

A significant causal association between C-reactive protein levels and schizophrenia
por: Inoshita, Masatoshi, et al.
Publicado: (2016)

Retraction: A significant causal association between C-reactive protein levels and schizophrenia
por: Inoshita, Masatoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_per88u2elf468sr7900vgm7kja